[1]
|
B. K. Srivastava, A. Joharapurkar, S. Raval, J. Z. Patel, R. Soni, P. Raval, A. Gite, A. Goswami, N. Sadhwani, N. Gandhi, H. Patel, B. Mishra, M. Solanki, B. Pandey, M. R. Jain and P. R. Patel. “Diaryl Dihydropyrazole-3-carboxamides with Significant in Vivo Antiobesity Activity Related to CB1 Receptor Antagonism:?Synthesis, Biological Evaluation, and Molecular Modeling in the Homology Model,” Journal of Medicinal Chemistry, Vol. 50, No. 24, 2007, pp. 5951-5966. doi:10.1021/jm061490u
|
[2]
|
S. Yamamoto, N. Tomita, Y. Suzuki, T. Suzaki, T. Kaku, T. Hara, M. Yamaoka, N. Kanzaki, A. Hasuoka, A. Baba and M. Ito, “Design, Synthesis, and Biological Evaluation of 4-Arylmethyl-1-phenylpyrazole and 4-Aryloxy-1- phenylpyrazole Derivatives as Novel Androgen Receptor Antagonists,” Bioorganic & Medicinal Chemistry, Vol. 20, No. 7, 2012, pp. 2338-2352.
doi:10.1016/j.bmc.2012.02.005
|
[3]
|
C. E. Mowbray, C. Burt, R. Corbau, M. Perros, I. Tran, P. A. Stupple, R. Webster and A. Wooda, “Pyrazole NNRTIs 1: Design and Initial Optimisation of a Novel Template,” Bioorganic & Medicinal Chemistry Letters, Vol. 19, No. 19, 2009, pp. 5599-5602.
doi:10.1016/j.bmcl.2009.08.039
|
[4]
|
G. R. Bebernitz, G. Argentieri, B. Battle, C. Brennan, B. Balkan, B. F. Burkey, M. Eckhardt, J. Gao, P. Kapa, R. J. Strohschein, H. F. Schuster, M. Wilson and D. D. Xu, “The Effect of 1,3-Diaryl-[1H]-pyrazole-4-acetamides on Glucose Utili-zation in ob/ob Mice,” Journal of Medicinal Chemistry, Vol. 44, No. 16, 2001, pp. 2601-2611.
doi:10.1021/jm010032c
|
[5]
|
A. A. Bekhit and T. Abdel-Aziem, “Design, Synthesis and Biological Evaluation of Some Pyrazole Derivatives as Anti-Inflammatory-Antimicrobial Agents,” Bioorganic & Medicinal Chemistry, Vol. 12, No. 8, 2004, 1935-1945.
doi:10.1016/j.bmc.2004.01.037
|
[6]
|
D. V. Dekhane, S. S. Pawar, S. Gupta, M. S. Shingare, C. R. Patil and S. N. Thore, “Synthesis and Anti-Inflammatory Activity of Some New 4,5-Dihydro-1,5-diaryl-1Hpyrazole-3-substituted-heteroazole Derivatives,” Bioorganic & Medicinal Chemistry Letters, Vol. 19, No. 21, 2011, pp. 6527-6532. doi:10.1016/j.bmcl.2011.08.061
|
[7]
|
F. R. Souza, V. T. Souza, V. Ratzlaff, L. P. Borges, M. R. Oliveira, H. G. Bonacorso, N. Zanatta, M. A. P. Martins and C. F. Mello, “Hypothermic and Antipyretic Effects of 3-Methyl- and 3-Phenyl-5-hydroxy-5-trichloromethyl-4,5- dihydro-1H-pyrazole-1-carboxyamides in Mice,” Euro-pean Journal of Pharmacology, Vol. 451, No. 2, 2002, pp. 141-147. doi:10.1016/S0014-2999(02)02225-2
|
[8]
|
M. Iovu, C. Zalaru, F. Dumitrascu, C. Draghici, M. Moraru and E. Criste, “New Substituted 2-(Pyrazol-1-yl)- dialkylacetanilides with Potential Local Anesthetic and Antiarrhythmic Action,” Il Farmaco, Vol. 58, 2003, pp. 301-307.
|
[9]
|
X.-F. Huang, X. Lu, Y. Zhang, G.-Q. Song, Q.-L. He, Q.-S. Li, X.-H. Yang, Y. Wei and H.-L. Zhu, “Synthesis, Biological Evaluation, and Molecular Docking Studies of N-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)aniline Derivatives as Novel Anticancer Agents,” Bioorganic & Medicinal Chemistry, Vol. 20, 2012, pp. 4895-4900.
|
[10]
|
X. Li, X. Lu, M. Xing, X.-H. Yang, T.-T. Zhao, H.-B. Gong and H.-L. Zhu, “Synthesis, Biological Evaluation, and Molecular Docking Studies of N,1,3-Triphenyl-1Hpyrazole-4-carboxamide Derivatives as Anticancer Agents,” Bioorganic & Medicinal Chemistry Letters, Vol. 22, 2012, pp. 3589-3593.
|
[11]
|
F. Chimenti, R. Fioravanti, A. Bolasco, F. Manna, P. Chimenti, D. Secci, O. Befani, P. Tu-rini, F. Ortuso and S. Alcaro, “Monoamine Oxidase Isoform-Dependent Tautomeric Influence in the Recognition of 3,5-Diaryl Pyrazole Inhibitors,” Journal of Medicinal Chemistry, Vol. 50, No. 3, 2007, pp. 425-428. doi:10.1021/jm060868l
|
[12]
|
L.-L. Xu, C.-J. Zheng, L.-P. Sun, J. Miao and H.-R. Piao, “Synthesis of Novel 1,3-Diaryl Pyrazole Derivatives Bearing Rhodanine-3-fatty Acid Moieties as Potential Antibacterial Agents,” European Journal of Medicinal Chemistry, Vol. 48, 2012, pp. 174-178.
doi:10.1016/j.ejmech.2011.12.011
|
[13]
|
J. Wen, Y. Fu, R.-Y. Zhang, J. Zhang, S.-Y. Chen and X.-Q. Yu, “A Simple and Efficient Synthesis of Pyrazoles in Water,” Tetrahedron, Vol. 67, No. 49, 2011, pp. 9618- 9621. doi:10.1016/j.tet.2011.09.074
|
[14]
|
M. V. Patel, R. Bell, S. Majest, R. Henry and T. Kolasa, “Synthesis of 4,5-Diaryl-1H-pyrazole-3-ol Derivatives as Potential COX-2 Inhibitors,” Journal of Organic Chemistry, Vol. 69, No. 21, 2004, pp. 7058-7065.
doi:10.1021/jo049264k
|
[15]
|
S. T. Heller and S. R. Natarajan, “1,3-Diketones from Acid Chlorides and Ketones:? A Rapid and General One-Pot Synthesis of Pyrazoles,” Organic Letters, Vol. 8, 2006, pp. 2675-2678.
|
[16]
|
P. Conti, A. Pinto, L. Tamborini, V. Rizzo and C. D. Micheli, “A Regioselective Route to 5-Substituted Pyrazole- and Pyrazoline-3-phosphonic Acids and Esters,” Tetrahedron, Vol. 63, No. 25, 2007, pp. 5554-5560.
doi:10.1016/j.tet.2007.04.027
|
[17]
|
V. K. Aggarwal, J. D. Vicente and R. V. Bonnert, “A Novel One-Pot Method for the Preparation of Pyrazoles by 1,3-Dipolar Cycloadditions of Diazo Compounds Generated in Situ,” Journal of Organic Chemistry, Vol. 68, No. 13, 2003, pp. 5381-5383. doi:10.1021/jo0268409
|
[18]
|
D. B. Sharp and C. S. Hamilton, “Derivatives of 1,2,4- Triazole and of Pyrazole,” Journal of the American Chemical Society, Vol. 68, No. 4, 1946, pp. 588-591.
doi:10.1021/ja01208a018
|
[19]
|
S. Abouricha, E. M. Rakib, N. Benchat, M. Alaoui, H. Allouchi and B. El Bali, “Facile Synthesis of New Spirothiadiazolopyridazines by 1,3-Dipolar Cycloaddition,” Synthetic Communication, Vol. 35, No. 16, 2005, pp. 2213-2221; doi:10.1080/00397910500182697
|
[20]
|
H. Sekkak, S. Mojahidi, E. M. Rakib, S. Abouricha, A. Kerbal, C. Aiello and M. Viale, “Synthesis and Antiproliferative Evaluation Of Spirothiadiazolopyridazine Derivatives,” Letters in Drug Design & Discovery, Vol. 7, No. 10, 2010, pp. 743-746.
doi:10.2174/1570180811007010743
|
[21]
|
T. Mossman, “Rapid Colorimetric Assay for Cellular Growth and Sur-vival: Application to Proliferation and Cytotoxicity Assays,” Journal of Immunological Methods Vol. 65, No. 1-2, 1983, pp. 55-63.
doi:10.1016/0022-1759(83)90303-4
|